166 related articles for article (PubMed ID: 30372873)
1. Synthesis, in vitro and in vivo anti-Trypanosoma cruzi and toxicological activities of nitroaromatic Schiff bases.
Cunha Almeida T; Gonzaga Ribeiro LH; Ferreira Dos Santos LB; da Silva CM; Tupinambá Branquinho R; de Lana M; Ramos Gadelha F; de Fátima Â
Biomed Pharmacother; 2018 Dec; 108():1703-1711. PubMed ID: 30372873
[TBL] [Abstract][Full Text] [Related]
2. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-Trypanosoma cruzi activity of diaryldiazepines.
Menezes JC; Vaz LB; de Abreu Vieira PM; da Silva Fonseca K; Carneiro CM; Taylor JG
Molecules; 2014 Dec; 20(1):43-51. PubMed ID: 25546620
[TBL] [Abstract][Full Text] [Related]
4. A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi.
Rodrigues JH; Ueda-Nakamura T; Corrêa AG; Sangi DP; Nakamura CV
PLoS One; 2014; 9(1):e85706. PubMed ID: 24465654
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo trypanocidal activity of a benzofuroxan derivative against Trypanosoma cruzi.
Dos Santos Petry L; Pillar Mayer JC; de Giacommeti M; Teixeira de Oliveira D; Razia Garzon L; Martiele Engelmann A; Magalhães de Matos AFI; Dellaméa Baldissera M; Dornelles L; Melazzo de Andrade C; Gonzalez Monteiro S
Exp Parasitol; 2021; 226-227():108125. PubMed ID: 34129877
[TBL] [Abstract][Full Text] [Related]
6. In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives.
Moreno-Viguri E; Jiménez-Montes C; Martín-Escolano R; Santivañez-Veliz M; Martin-Montes A; Azqueta A; Jimenez-Lopez M; Zamora Ledesma S; Cirauqui N; López de Ceráin A; Marín C; Sánchez-Moreno M; Pérez-Silanes S
J Med Chem; 2016 Dec; 59(24):10929-10945. PubMed ID: 28002965
[TBL] [Abstract][Full Text] [Related]
7. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.
Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F
Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Biological in vitro and in vivo Evaluation of 2-(5-Nitroindazol-1-yl)ethylamines and Related Compounds as Potential Therapeutic Alternatives for Chagas Disease.
Martín-Escolano R; Aguilera-Venegas B; Marín C; Martín-Montes Á; Martín-Escolano J; Medina-Carmona E; Arán VJ; Sánchez-Moreno M
ChemMedChem; 2018 Oct; 13(19):2104-2118. PubMed ID: 30098232
[TBL] [Abstract][Full Text] [Related]
9. Novel coumarins active against Trypanosoma cruzi and toxicity assessment using the animal model Caenorhabditis elegans.
Soares FGN; Göethel G; Kagami LP; das Neves GM; Sauer E; Birriel E; Varela J; Gonçalves IL; Von Poser G; González M; Kawano DF; Paula FR; de Melo EB; Garcia SC; Cerecetto H; Eifler-Lima VL
BMC Pharmacol Toxicol; 2019 Dec; 20(Suppl 1):76. PubMed ID: 31852548
[TBL] [Abstract][Full Text] [Related]
10. Trypanocidal activity and selectivity in vitro of aromatic amidine compounds upon bloodstream and intracellular forms of Trypanosoma cruzi.
De Souza EM; da Silva PB; Nefertiti AS; Ismail MA; Arafa RK; Tao B; Nixon-Smith CK; Boykin DW; Soeiro MN
Exp Parasitol; 2011 Feb; 127(2):429-35. PubMed ID: 20971106
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo biological effects of novel arylimidamide derivatives against Trypanosoma cruzi.
Timm BL; da Silva PB; Batista MM; da Silva FH; da Silva CF; Tidwell RR; Patrick DA; Jones SK; Bakunov SA; Bakunova SM; Soeiro Mde N
Antimicrob Agents Chemother; 2014 Jul; 58(7):3720-6. PubMed ID: 24752263
[TBL] [Abstract][Full Text] [Related]
12. Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period.
Duschak VG
Recent Pat Antiinfect Drug Discov; 2016; 11(2):74-173. PubMed ID: 27784230
[TBL] [Abstract][Full Text] [Related]
13. Diaminomaleonitrile derivatives as new potential antichagasic compounds: a study of structure-activity relationships.
de Oliveira AS; S Mello LD; H Ogihara C; H Döring T; L Palomino-Salcedo D; Michelan-Duarte S; Lg Ferreira L; M Souza J; Dávila-Rodríguez MJ; Cruz Júnior JWD; R Dockal E; D Andricopulo A
Future Med Chem; 2021 Dec; 13(24):2167-2183. PubMed ID: 34708659
[No Abstract] [Full Text] [Related]
14. In vitro and in vivo antiparasitic activity of Physalis angulata L. concentrated ethanolic extract against Trypanosoma cruzi.
Meira CS; Guimarães ET; Dos Santos JA; Moreira DR; Nogueira RC; Tomassini TC; Ribeiro IM; de Souza CV; Ribeiro Dos Santos R; Soares MB
Phytomedicine; 2015 Oct; 22(11):969-74. PubMed ID: 26407938
[TBL] [Abstract][Full Text] [Related]
15. Investigating the structure-activity relationships of N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds.
Palace-Berl F; Pasqualoto KFM; Zingales B; Moraes CB; Bury M; Franco CH; da Silva Neto AL; Murayama JS; Nunes SL; Silva MN; Tavares LC
Eur J Med Chem; 2018 Jan; 144():29-40. PubMed ID: 29247858
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of new sulfonamide derivatives as potential anti-Trypanosoma cruzi agents.
Bocanegra-Garcia V; Villalobos-Rocha JC; Nogueda-Torres B; Lemus-Hernandez ME; Camargo-Ordonez A; Rosas-Garcia NM; Rivera G
Med Chem; 2012 Nov; 8(6):1039-44. PubMed ID: 22762161
[TBL] [Abstract][Full Text] [Related]
17. Identification of three classes of heteroaromatic compounds with activity against intracellular Trypanosoma cruzi by chemical library screening.
Bettiol E; Samanovic M; Murkin AS; Raper J; Buckner F; Rodriguez A
PLoS Negl Trop Dis; 2009; 3(2):e384. PubMed ID: 19238193
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of new 1,2,3-triazoles derived from eugenol and analogues with in vitro and in vivo activity against Trypanosoma cruzi.
Reis RCFM; Dos Santos EG; Benedetti MD; Reis ACC; Brandão GC; Silva GND; Diniz LA; Ferreira RS; Caldas IS; Braga SFP; Souza TB
Eur J Med Chem; 2023 Oct; 258():115622. PubMed ID: 37441850
[TBL] [Abstract][Full Text] [Related]
19. 2-(phenylthio)ethylidene derivatives as anti-Trypanosoma cruzi compounds: Structural design, synthesis and antiparasitic activity.
Cardoso MVO; Oliveira Filho GB; Siqueira LRP; Espíndola JWP; Silva EBD; Mendes APO; Pereira VRA; Castro MCAB; Ferreira RS; Villela FS; Costa FMRD; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2019 Oct; 180():191-203. PubMed ID: 31306906
[TBL] [Abstract][Full Text] [Related]
20. Trypanocidal Activity of Flavanone Derivatives.
Maciel Diogo G; Andrade JS; Sales Junior PA; Maria Fonseca Murta S; Dos Santos VMR; Taylor JG
Molecules; 2020 Jan; 25(2):. PubMed ID: 31963596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
